[6]
Davies, J. Antibiotic resistance in mycobacteria. Genetics and Tuberculosis, Novartis Foundation Symposia, John Wiley and Sons. Limited., 1998, 34, 195.
[7]
Buu-Hoi, N.P.; Xuong, N.D. Sur les composées tubercu-lostatiques du groupe de la thiourée et leur mecanisme d’action. Compt. rend. Acad. Sci., 1953, 237, 498-500.
[8]
Kharizanova, T.; Kozhukharov, P.; Gusteva, D.; Simova, V. Antitubercular activity of thiocarbamide derivatives. Far-matsiya (Sofia, Bulgaria), 1969, 19, 33-38.
[9]
Kulkarni, S.; Kamath, S.; Devasthale, S.; Hooper, M. An-tituberculosis compounds. Part VII. Towards the design of novel antimycobacterial agents. Indian Drugs, 1988, 25, 464-466.
[10]
Shinde, B.R.; Shinde, N.M.; Parab, G.S. Thiourea deriva-tives as antitubercular compounds. Curr. Sci., 1982, 51, 704-705.
[12]
Lambelin, G.; Parmentier, R. The toxicity of isoxyl. Arzneimittelforschung, 1966, 16, 881-886.
[16]
Zucchetto, C. Clinical observations on the employment of 4,4′-di(isoamyloxy)thiocarbanilide (Isoxyl) in pulmonary tu-berculosis therapy. Arch. Tisiol. Mal. Appar. Respir., 1967, 22, 590-608.
[26]
Kawle, P.; Deohate, P. MW induced preparation of acridin-9-yl-bis-benzothiazol-2-yl-amines and antituberculosis activity. Am. J. Pharm. Tech. Res., 2016, 6, 216-222.
[27]
Fussenegger, M.; Weber, W.; Schoenmakers, R. Composition for treatment of tuberculosis. United States Patent 9050295, Chem. Abstr., 2015.
[29]
Hearn, M.J. Derivatives of phenyl 4-aminosalicylate and method of making the same. United States Patent 6,600,063, Chem. Abstr., 2003.
[30]
Hearn, M.J. Antimycobacterial compounds and method for making the same. United States Patent 6,846,933 Chem. Abstr, 2001.
[32]
Dubenko, R.; Pel’kis, P. Symmetrical derivatives of 1,6-diarylhydrazodithiodicarboxamide. Ukrains’kii Khemichnii Zhurnal, 1961, 27, 669-671.
[34]
Janniah, S.; Guha, P. Constitution of the so-called dithiourazole of Martin Freund. V. Isomerism of hydrazodithiodicar-boxamides, iminothiolthiobiazoles and di-R-iminothiobiazoles. J. Indian Inst. Sci., 1933, 16A, 11-18.
[35]
Grammaticakis, P. The absorption in the middle ultraviolet and the visible of α,β-disubstituted hydrazines and their oxidation products. III. Diacylhydrazines, diacyldiimides, and 1,3,4-oxadiazoles. Bull. Soc. Chim. Fr., 1953, 12, 86-93.
[37]
Eberhardt, U.; Depner, J. Thiocarbamoylhydrazine derivatives in veterinary pharmaceuticals. Part 2. Transformation of tri-aminoguanidine with mustard. Pharmazie, 1977, 32, 458-460.
[39]
Abbasi, M.; Trivedi, J. Synthesis of 1-aryl(alkyl)(aralkyl) dithiourazoles. J. Indian Chem. Soc., 1965, 42, 333-335.
[40]
Katritzky, A.; Khashab, N.; Gromova, A. Preparations of diversely substituted thiosemicarbazides and N-hydroxythioureas. ARKIVOC, 2006, 3, 226-236.
[41]
Drobnica, L.; Kristian, P.; Augustin, J. The Chemistry of the -NCS Group.The Chemistry of Cyanates and Their Thio Derivatives; John Wiley and Sons, 1977, pp. 1003-1221.
[45]
Vestal, A. Procedures for the isolation and identification of mycobacteria. Public Health Service Publication No. 1995, Laboratory Division, National Communicable Disease Center, 1995, 113-115.
[48]
Jayaraman, P.; Siddiqi, M.; Sakharkar, M.; Chandra, R.; Sakharkar, K. Hypothesis-driven multi-target drug design; Drug and Vaccine Dev, 2015.